Zilretta
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5401 W Kennedy Blvd Lincoln Ctr Ste 890,...Phone Number
(866) 407-6180Website
www.zilretta.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Zilretta
Pacira Pharmaceuticals, Inc. offers ZILRETTA, an FDA-approved extended-release corticosteroid injection specifically designed to manage osteoarthritis knee pain without the use of opioids. This innovative treatment utilizes microsphere technology to provide significant pain relief for up to three months with a single injection. The company targets healthcare professionals and patients suffering from osteoarthritis, providing resources and support for those seeking treatment options. Additionally, Pacira offers a co-pay program to assist patients with the costs associated with ZILRETTA injections.Explore more
Zilretta Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zilretta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Zilretta, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Zilretta had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Zilretta
Funding: Get notified immidiatlly once Zilretta has new funding data
Earning: See what the market has to say on Zilretta recently announced quarterly report
Check if Zilretta has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Zilretta launches new products
Website visits: Recent activity has been detected on your website
Check out if Zilretta is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Zilretta
Compare insights from companies similar to Zilretta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Zilretta is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zilretta is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zilretta.
Zilretta Tech Stack
A closer look at the technologies used by Zilretta
Zilretta News & Media
Flexion Therapeutics Announces Publication of Results from Phase 2 Pharmacokinetics (PK) and Safety Study of ZILRETTA® in Shoulder Osteoarthritis (OA)
BURLINGTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced that the results from the randomized, open-label, Phase 2 pharmacokinetic (PK) trial of ZILRETTA (triamcinolone acetonide extended-release injectable suspension) were published in Drugs in R&D. The study compared the plasma PK profile of ZILRETTA to immediate-release triamcinolone acetonide in crystalline suspension (TAcs) and assessed the safety and general tolerability of ZILRETTA in osteoarNational Basketball Retired Players Association, Sheryl Swoopes and Flexion Therapeutics Announce Partnership to Raise Awareness of ZILRETTA®
- Sheryl Swoopes, WNBA Legend, Basketball Hall of Famer and ZILRETTA Patient, Tips Off Educational Campaign About ZILRETTA and Osteoarthritis Knee Pain - Sheryl Swoopes, WNBA Legend, Basketball Hall of Famer and ZILRETTA Patient, Tips Off Educational Campaign About ZILRETTA and Osteoarthritis Knee PainFlexion Therapeutics Announces Preliminary Third-Quarter 2020 ZILRETTA® Net Sales of Approximately $23.6 Million
Company to hold conference call today at 8:30 a.m. ET Company to hold conference call today at 8:30 a.m. ETFlexion Therapeutics Reports Second-Quarter 2020 Financial Results and Recent Business Highlights
BURLINGTON, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today reported financial results and recent business highlights for the quarter ended June 30, 2020.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Zilretta
Sign Up For FreeTo access detailed company insights
Pacira Pharmaceuticals, Inc. offers ZILRETTA, an FDA-approved extended-release corticosteroid injection specifically designed to manage osteoarthritis knee pain without the use of opioids. This innovative treatment utilizes microsphere technology to provide significant pain relief for up to three months with a single injection. The company targets... Read More
